Investors Urged to Take Action in LifeMD Class Action Lawsuit Today
On October 15, 2025, Berger Montague PC announced a significant class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD), aimed at protecting investors who acquired shares during a specific period from May 7, 2025 to August 5, 2025. This announcement comes amidst serious allegations against LifeMD regarding misleading statements about its financial standing and business operations. The law firm has taken a proactive stance, urging impacted investors to act before the imminent deadline of October 27, 2025, to secure their position as lead plaintiffs in this legal battle.
LifeMD, a telehealth provider based in New York, is at the center of these allegations. The lawsuit claims that the company overstated its competitive edge and financial guidance for 2025 without adequately addressing increasing costs associated with customer acquisition, particularly in its RexMD segment, which deals with obesity-related medications. As a result of these alleged false claims, when the reality began to surface, LifeMD stocks experienced a dramatic decline of 44% in a single trading day.
This steep decline underscores the significance of the investors’ plight, as they face potential losses due to the company’s failure to disclose material facts accurately. Investors interested in participating in the lawsuit are encouraged to learn about their rights and the necessary steps to take in order to be part of the class action.
According to Berger Montague, timing is of the essence. The deadline to appoint a lead plaintiff representative for the class action is fast approaching. Investors are advised not to delay in seeking legal counsel to understand their options fully. The consequences of failing to act could mean forfeiting their chance for recourse and financial recovery.
Berger Montague PC has been a notable figure in securities class action litigation since its inception in 1970. With multiple offices across the United States, the firm has an established reputation for fighting on behalf of both individual and institutional investors. Their experience and dedication to protecting the rights of shareholders have solidified their role as leading counsel in related cases.
Investors wishing to learn more about the class action against LifeMD can directly contact Berger Montague. They can reach out to Andrew Abramowitz, Senior Counsel, at 215-875-3015 or via email, or connect with Caitlin Adorni, who oversees portfolio and institutional client monitoring services, at 267-764-4865. More details about the lawsuit and how to proceed can also be found on Berger Montague's website.
The stakes are high and the window for action is limited. Investors must remain vigilant and proactive to protect their investments and ensure they are not left vulnerable in the wake of LifeMD’s troubling developments. Securing the right legal support in a timely manner is imperative to navigate this challenging situation successfully.
Nature of the Lawsuit
LifeMD, a telehealth provider based in New York, is at the center of these allegations. The lawsuit claims that the company overstated its competitive edge and financial guidance for 2025 without adequately addressing increasing costs associated with customer acquisition, particularly in its RexMD segment, which deals with obesity-related medications. As a result of these alleged false claims, when the reality began to surface, LifeMD stocks experienced a dramatic decline of 44% in a single trading day.
This steep decline underscores the significance of the investors’ plight, as they face potential losses due to the company’s failure to disclose material facts accurately. Investors interested in participating in the lawsuit are encouraged to learn about their rights and the necessary steps to take in order to be part of the class action.
Why Should Investors Act Now?
According to Berger Montague, timing is of the essence. The deadline to appoint a lead plaintiff representative for the class action is fast approaching. Investors are advised not to delay in seeking legal counsel to understand their options fully. The consequences of failing to act could mean forfeiting their chance for recourse and financial recovery.
About Berger Montague
Berger Montague PC has been a notable figure in securities class action litigation since its inception in 1970. With multiple offices across the United States, the firm has an established reputation for fighting on behalf of both individual and institutional investors. Their experience and dedication to protecting the rights of shareholders have solidified their role as leading counsel in related cases.
How to Get Involved
Investors wishing to learn more about the class action against LifeMD can directly contact Berger Montague. They can reach out to Andrew Abramowitz, Senior Counsel, at 215-875-3015 or via email, or connect with Caitlin Adorni, who oversees portfolio and institutional client monitoring services, at 267-764-4865. More details about the lawsuit and how to proceed can also be found on Berger Montague's website.
The stakes are high and the window for action is limited. Investors must remain vigilant and proactive to protect their investments and ensure they are not left vulnerable in the wake of LifeMD’s troubling developments. Securing the right legal support in a timely manner is imperative to navigate this challenging situation successfully.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.